Market Research Logo

Global Liquid Biopsy Market 2018-2022

Global Liquid Biopsy Market 2018-2022

About Liquid Biopsy

Liquid biopsy is also called fluid biopsy or fluid phase biopsy. It is a simple and non-invasive test to detect genetic changes in the tumor through a simple blood or urine sample. The preference toward liquid biopsy is significantly increasing over traditional tissue biopsy due to its less invasive nature and growing focus on personalized medicine in oncology diagnosis and treatment.

Technavio’s analysts forecast the global liquid biopsy market to grow at a CAGR of 34.25% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global liquid biopsy market for 2018-2022. To calculate the market size, the report considers the revenue generated by the use of the liquid biopsy technologies including CTC and ctDNA and exosome and RNA.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Liquid Biopsy Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • BIOCEPT
  • Exosome Diagnostics
  • F. Hoffmann-La Roche
  • GUARDANT HEALTH
  • Myriad Genetics
  • QIAGEN
Market driver
  • Growing focus on personalized medicine for cancer care
  • For a full, detailed list, view our report
Market challenge
  • Dearth of skilled technicians
  • For a full, detailed list, view our report
Market trend
  • Emerging applications of liquid biopsy
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Global IVD market
      • Table Global IVD market segmentation
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Global liquid biopsy market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global liquid biopsy market – Market size and forecast 2017-2022 ($ mn)
      • Table Global liquid biopsy market – Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by technology
    • Segmentation by technology
      • Table Global liquid biopsy market by technology – Market share 2017-2022 (%)
    • Comparison by technology
      • Table Global liquid biopsy market – Comparison by technology
    • CTC and ctDNA
      • Table Global CTC and ctDNA market – Market size and forecast 2017-2022 ($ mn)
      • Table Global CTC and ctDNA market – Year-over-year growth 2018-2022 (%)
    • Exosome and RNA
      • Table Global exosome and RNA market – Market size and forecast 2017-2022 ($ mn)
      • Table Global exosome and RNA market – Year-over-year growth 2018-2022 (%)
    • Market opportunity by technology
      • Table Market opportunity by technology
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global liquid biopsy market by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Liquid biopsy market in Americas
      • Table Liquid biopsy market in Americas – Market size and forecast 2017-2022 ($ mn)
      • Table Liquid biopsy market in Americas – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • Liquid biopsy market in EMEA
      • Table Liquid biopsy market in EMEA – Market size and forecast 2017-2022 ($ mn)
      • Table Liquid biopsy market in EMEA – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • Liquid biopsy market in APAC
      • Table Liquid biopsy market in APAC – Market size and forecast 2017-2022 ($ mn)
      • Table Liquid biopsy market in APAC – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Increasing funding/investment for liquid biopsy
    • Strategic partnerships and M&A
    • Emerging applications of liquid biopsy
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • BIOCEPT
      • Table BIOCEPT – Overview
      • Table BIOCEPT – Business segments
      • Table BIOCEPT – Organizational developments
      • Table BIOCEPT – Geographic focus
      • Table BIOCEPT – Key offerings
      • Table BIOCEPT – Key customers
    • Exosome Diagnostics
      • Table Exosome Diagnostics – Overview
      • Table Exosome Diagnostics – Business segments
      • Table Exosome Diagnostics – Organizational developments
      • Table Exosome Diagnostics – Geographic focus
      • Table Exosome Diagnostics – Key offerings
      • Table Exosome Diagnostics – Key customers
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche – Overview
      • Table F. Hoffmann-La Roche – Business segments
      • Table F. Hoffmann-La Roche – Organizational developments
      • Table F. Hoffmann-La Roche – Geographic focus
      • Table F. Hoffmann-La Roche – Segment focus
      • Table F. Hoffmann-La Roche – Key offerings
      • Table F. Hoffmann-La Roche – Key customers
    • GUARDANT HEALTH
      • Table GUARDANT HEALTH – Overview
      • Table GUARDANT HEALTH – Business segments
      • Table GUARDANT HEALTH – Organizational developments
      • Table GUARDANT HEALTH – Geographic focus
      • Table GUARDANT HEALTH – Key offerings
      • Table GUARDANT HEALTH – Key customers
    • Myriad Genetics
      • Table Myriad Genetics – Overview
      • Table Myriad Genetics – Business segments
      • Table Myriad Genetics – Organizational developments
      • Table Myriad Genetics – Geographic focus
      • Table Myriad Genetics – Segment focus
      • Table Myriad Genetics – Key offerings
      • Table Myriad Genetics – Key customers
    • QIAGEN
      • Table QIAGEN – Overview
      • Table QIAGEN – Product categories
      • Table QIAGEN – Organizational developments
      • Table QIAGEN – Geographic focus
      • Table QIAGEN – Product category focus
      • Table QIAGEN – Key offerings
      • Table QIAGEN – Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report